AI recognizes cognitive decline in headshots

Researchers have used deep learning software to accurately detect age-related cognitive impairment using only photos of patients’ faces.

The work was conducted at the University of Tokyo and is described in a paper published Jan. 25 by Aging (Albany, NY).

Testing five deep learning models pre-trained on existing image sets, the team found the best-performing model achieved 93% accuracy at separating 121 impaired patients from 117 healthy volunteers.

Further, the researchers found “close and significant” correlations between face AI scores and those from a standardized assessment questionnaire, the Mini-Mental State Examination (aka Folstein test).

Interestingly, they also found close correlation between face AI scores and chronological age—and stronger correlation between the AI and the questionnaire than between the questionnaire and chronological age.

From these results the authors conclude that deep learning software “has the ability to differentiate facial images of people with mild dementia from those of people without dementia. This may pave the way for the clinical use of facial images as a biomarker of dementia.”

The study is available in full for free.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

If the Trump administration continues taking a laissez-faire stance toward AI—including AI used in healthcare—why not let the states go it alone on regulating the technology? 

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.